Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Agilon Health Inc’s stock clocked out at $4.32, up 2.86% from its previous closing price of $4.20. In other words, the price has increased by $2.86 from its previous closing price. On the day, 6.09 million shares were traded. AGL stock price reached its highest trading level at $4.34 during the session, while it also had its lowest trading level at $4.125.
Ratios:
To gain a deeper understanding of AGL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.27. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on January 10, 2025, Upgraded its rating to Neutral and sets its target price to $2.25 from $1.75 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when McLoughlin Karen bought 25,000 shares for $2.20 per share. The transaction valued at 55,085 led to the insider holds 73,166 shares of the business.
Battaglia Silvana bought 25,062 shares of AGL for $50,269 on Dec 11 ’24. The Director now owns 66,144 shares after completing the transaction at $2.01 per share. On Nov 25 ’24, another insider, MCKENZIE DIANA, who serves as the Director of the company, bought 12,500 shares for $2.28 each. As a result, the insider paid 28,474 and bolstered with 51,319 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGL now has a Market Capitalization of 1781149056 and an Enterprise Value of 1425144192. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 3.78. Its current Enterprise Value per Revenue stands at 0.235 whereas that against EBITDA is -5.492.
Stock Price History:
The Beta on a monthly basis for AGL is 0.46, which has changed by -0.21597093 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, AGL has reached a high of $7.73, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is 29.33%, while the 200-Day Moving Average is calculated to be 9.01%.
Shares Statistics:
It appears that AGL traded 5.39M shares on average per day over the past three months and 7104650 shares per day over the past ten days. A total of 412.19M shares are outstanding, with a floating share count of 303.58M. Insiders hold about 26.37% of the company’s shares, while institutions hold 71.67% stake in the company. Shares short for AGL as of 1740700800 were 16819686 with a Short Ratio of 3.12, compared to 1738281600 on 20237578. Therefore, it implies a Short% of Shares Outstanding of 16819686 and a Short% of Float of 16.1.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
